INS and Hyperinsulinemia: To investigate whether mTORC1 signaling mediates CCRK-promoted insulin resistance, we treated LO2-CCRK cells in hyperinsulinemia condition and found that induction of CCRK further impaired insulin sensitivity (Fig. 5g, lane 6 vs. lane 4).